Research Analysts Offer Predictions for Maximus, Inc.’s Q1 2025 Earnings (NYSE:MMS)

Maximus, Inc. (NYSE:MMS) – Stock analysts at Zacks Research reduced their Q1 2025 EPS estimates for Maximus in a research report issued on Tuesday, April 23rd. Zacks Research analyst R. Department now anticipates that the health services provider will post earnings of $1.39 per share for the quarter, down from their prior estimate of $1.40. The consensus estimate for Maximus’ current full-year earnings is $5.42 per share. Zacks Research also issued estimates for Maximus’ Q2 2025 earnings at $1.21 EPS, FY2025 earnings at $5.36 EPS and Q1 2026 earnings at $1.22 EPS.

A number of other research analysts also recently commented on the stock. StockNews.com raised shares of Maximus from a “hold” rating to a “buy” rating in a research report on Thursday, February 8th. Raymond James lowered Maximus from an “outperform” rating to a “market perform” rating in a report on Wednesday, January 3rd.

Maximus Stock Performance

Shares of Maximus stock opened at $80.63 on Thursday. The company has a quick ratio of 1.69, a current ratio of 1.69 and a debt-to-equity ratio of 0.71. Maximus has a 52 week low of $72.39 and a 52 week high of $89.69. The firm’s 50 day moving average is $82.59 and its two-hundred day moving average is $81.30. The firm has a market capitalization of $4.92 billion, a P/E ratio of 26.66 and a beta of 0.72.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Wednesday, February 7th. The health services provider reported $1.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.28 by $0.06. Maximus had a return on equity of 15.68% and a net margin of 3.73%. The company had revenue of $1.33 billion during the quarter, compared to the consensus estimate of $1.29 billion. During the same period in the previous year, the business earned $0.94 EPS. Maximus’s revenue for the quarter was up 6.2% on a year-over-year basis.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 31st. Stockholders of record on Wednesday, May 15th will be issued a $0.30 dividend. The ex-dividend date of this dividend is Tuesday, May 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 1.49%. Maximus’s payout ratio is 39.74%.

Insider Activity at Maximus

In other Maximus news, CFO David Mutryn sold 8,000 shares of the firm’s stock in a transaction on Friday, February 16th. The shares were sold at an average price of $83.95, for a total transaction of $671,600.00. Following the transaction, the chief financial officer now directly owns 5,124 shares of the company’s stock, valued at approximately $430,159.80. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 1.40% of the stock is owned by insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Norges Bank purchased a new stake in shares of Maximus in the fourth quarter valued at about $55,821,000. FMR LLC increased its position in Maximus by 6.4% during the 3rd quarter. FMR LLC now owns 8,588,189 shares of the health services provider’s stock worth $641,366,000 after purchasing an additional 514,698 shares during the period. Public Employees Retirement Association of Colorado raised its stake in shares of Maximus by 1,984.0% during the 4th quarter. Public Employees Retirement Association of Colorado now owns 335,094 shares of the health services provider’s stock worth $28,101,000 after buying an additional 319,015 shares in the last quarter. Van Berkom & Associates Inc. raised its stake in shares of Maximus by 22.3% during the 3rd quarter. Van Berkom & Associates Inc. now owns 1,124,238 shares of the health services provider’s stock worth $83,958,000 after buying an additional 204,796 shares in the last quarter. Finally, Assenagon Asset Management S.A. acquired a new stake in shares of Maximus in the 3rd quarter valued at approximately $13,451,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.